Questionnaire Survey for Postoperative Urothelial Carcinoma
Not Applicable
- Conditions
- rothelial carcinoma
- Registration Number
- JPRN-UMIN000046978
- Lead Sponsor
- Ono Pharmaceutical Co., Ltd. Bristol-Myers Squibb K.K.
- Brief Summary
Patients who answered as anxious accounted for 70.9% and 49.5% before and 1 to < 2 years after operation, respectively. Surgeons thought that 91.8% of patients felt anxiety before operation, but it decreased to 26.4% 1 to < 2 years after operation. Possible cancer recurrence was the most common anxiety (before operation, 80.0%; 1 to < 2 years after operation, 56.7%). The second most common anxiety was trouble with urination (before operation, 51.8%; 1 to < 2 years after operation, 26.8%).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 220
Inclusion Criteria
Not provided
Exclusion Criteria
Patients or their family members who are engaged in a pharmaceutical, medical, or survey-related job
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of respondents with anxiety and worry in patients underwent urothelial carcinoma surgery and the changes over time from baseline
- Secondary Outcome Measures
Name Time Method Percentage of respondents with recognition about patient's anxiety and worry in patients underwent urothelial cancer surgery and the changes over times from baseline/ Willingness for adjuvant therapy in patients underwent urothelial carcinoma surgery/ The extent to which patients are conveying their anxiety to their physicians/ Actual treatment status and goals of physicians with experience of surgery for urothelial cancer